On the amendments of a compulsory and final expression of a stock redemption offer’s prospectus of akciju sabiedrība “LATVIJAS TILTI”
/
Date10 Jan 2017
Hereby akciju sabiedrība “LATVIJAS TILTI” informs that: – On the 5th of January 2017 offeror – SIA “LNK (Latvijas Novitātes Komplekss)” (registration number 40003000252, legal... Read More →
RedHill Biopharma Announces First Dosing in RHB-105 Supportive PK Studies Ahead of Confirmatory Phase III Study for H. pylori Infection
/
Date10 Jan 2017
The first group of subjects have been dosed in a single-dose three-way crossover pharmacokinetic (PK) study with RHB-105 versus the active comparators in the confirmatory... Read More →
CAPMAN PLC HAS ANNOUNCED THE PRELIMINARY RESULT OF THE SUBSEQUENT OFFER PERIOD OF THE EXCHANGE OFFER
/
Date10 Jan 2017
Helsinki, Finland, 2017-01-10 14:30 CET (GLOBE NEWSWIRE) — Norvestia Oyj Stock Exchange Release 10 January 2017 at 15:30 This stock exchange release may... Read More →
Fiasp® (fast-acting insulin aspart) approved in Europe
/
Date10 Jan 2017
Bagsværd, Denmark, 10 January 2017 – Novo Nordisk today announced that the European Commission has granted marketing authorisation for Fiasp® for the treatment of diabetes in... Read More →
Chembio Completes Acquisition of Malaysia-based RVR Diagnostics
/
Date10 Jan 2017
MEDFORD, N.Y., Jan. 10, 2017 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that... Read More →
Capital Bank Financial Corp. Sets Earnings Release and Conference Call Date for Fourth-Quarter 2016 Results
/
Date10 Jan 2017
Charlotte, N.C., Jan. 10, 2017 (GLOBE NEWSWIRE) — Capital Bank Financial Corp. (Nasdaq: CBF) today announced that it will release its fourth-quarter 2016 financial results... Read More →
Cytori to Expand Scleroderma Focus to Broader Hand Therapy Franchise Under the Habeo™ Cell Therapy Brand
/
Date10 Jan 2017
SAN DIEGO, Jan. 10, 2017 (GLOBE NEWSWIRE) — Cytori Therapeutics, Inc. (NASDAQ:CYTX), as part of its corporate update at the Biotech Showcase, announced its intention... Read More →
TestEquity acquires JENSEN Tools + Supply
/
Date10 Jan 2017
TestEquity acquires JENSEN Tools + Supply TestEquity acquires JENSEN Tools + Supply JENSEN Tools + Supply MOORPARK, Calif., Jan. 10, 2017 (GLOBE NEWSWIRE) — TestEquity,... Read More →
Fiasp® (hurtigtvirkende insulin aspart) godkendt i Europa
/
Date10 Jan 2017
PR170110_Fiasp_EMA_approval_DK.pdf Bagsværd, den 10. januar 2017 – Novo Nordisk meddeler i dag, at Europa-Kommissionen har givet markedsføringstilladelse til Fiasp® til behandling af diabetes hos voksne.... Read More →
4 Things Gilead Sciences' CEO Says to Expect in 2017
/
Date10 Jan 2017
Anyone expecting a surprise from Gilead Sciences ‘(NASDAQ: GILD) presentation at the 35th Annual J.P. Morgan Healthcare Conference on Monday would have walked away disappointed.... Read More →